Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Eye Neoplasms × MART-1 Antigen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 10 Uveal Melanoma 4 Neoplasms 3 Urologic Neoplasms 1 Skin Neoplasms 1 Neoplasm Metastasis 1 Eye Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

montanide ISA 51 1 Proton Therapy 1 Peptides 1 Melphalan 1 MART-1 Antigen 1 MAGEA3 protein, human 1 Leuprolide 1 Laparotomy 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00020475 2024-03-04

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

National Cancer Institute (NCI)

Phase 2 Completed

Uveal Melanoma, Eye Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡